Ramiro Ribeiro insider trades: EyePoint (EYPT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ramiro reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | EYPT | ↓ Sell | 2,438 | $17.87 | $44K | Direct | Mar 5, 2026 (1d) |
| Feb 17, 2026 | EYPT | ↓ Sell | 2,437 | $15.00 | $37K | Direct | Feb 18, 2026 (1d) |
| Jan 5, 2026 | EYPT | ↓ Sell | 42,544 | $17.10 | $727K | Direct | Jan 7, 2026 (2d) |
| Nov 11, 2025 | EYPT | ↓ Sell | 2,722 | $11.61 | $32K | Direct | Nov 12, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EYPT insiders
Open-market trades in the last 12 months
About Ramiro Ribeiro's insider trades
Ramiro Ribeiro is Chief Medical Officer at EyePoint (EYPT). Since Nov 11, 2025, Ramiro has reported no open-market purchases and 4 sales worth $839K on SEC Form 4. In the last 12 months: 4 sales ($839K).
Their filings also include option exercises (4 filings), grants and awards (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EYPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.